Montelukast sodium is indicated for prevention of exercise-induced bronchoconstriction (EIB) in patients 6 years of age and older
Generic name: montelukast [ mon-te-LOO-kast ] Drug class: Leukotriene modifiers
4 mg montelukast sodium, which is equivalent to 10 mg of montelukast, and the following inactive
Montelukast 10 mg (base) is not a controlled substance under the Controlled Substances Act (CSA)
For oral dosage form (tablets): Adults and children 15 years of age and older—10 milligrams (mg) once a day in the evening
Rating
hives or welts
Each beige, square-shaped, biconvex, film-coated tablet, engraved with "10" on one side, contains 10 mg of montelukast in the form of montelukast sodium
When montelukast is used to prevent breathing difficulties during exercise, it should be taken at least 2 hours before Common Singulair side effects may include: stomach pain, diarrhea; fever or other flu symptoms; ear pain or full feeling, trouble hearing; headache; or
pain, redness, or swelling in the ear
Each tablet contains montelukast sodium which corresponds to 10 mg of montelukast
Bottom Line
Each 10-mg film-coated SINGULAIR tablet contains 10
Excipients with known effect (Film Coated Tablet): Mannitol with other products containing the same active ingredient, montelukast
Ease of Use
Montelukast sodium, USP, the active ingredient in montelukast sodium tablets, USP, 2
Montelukast (as Montelukast sodium) 10 mg
97
Rapidly absorbed from the GI tract; peak plasma concentrations attained within 3–4, 2–2
Montelukast sodium, the active ingredient in montelukast sodium chewable tablets, USP, is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT 1 receptor